13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation | Perpustakaan Fakultas Kedokteran dan Ilmu Kesehatan

Pencarian berdasarkan :

SEMUA Pengarang Subjek ISBN/ISSN Pencarian Spesifik

Pencarian terakhir:

Image of 13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation

Artikel

13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation

DISTLER, ANDREAS - Nama Orang; DEBBIE PAPPELENDAM - Nama Orang;

Summary Background:e Paul-Ehrlich-Institut (PEI) pub-lished an analysis of reports of adverse drug re-actions (ADRs) in 2001 with test and therapy allergens from the period from 1991 to 2000. Pos-sible risk factors were evaluated for the ADR re-ports classied as “serious”. During the analyzed period, modied semi-depot preparations (aller-goids) induced between 0.01 % and 0.0005 % seri-ous systemic reactions, i. e. one serious ADR occurred in 10,000 to 200,000 injections. No in-formation was provided regarding the respective incidences in relation to the individual companies or preparations. Materials and methods: Within the scope of a 13-year analysis (2001–2013), the serious ADRs were analysed at HAL for the allergoid prepara-tions PURETHAL® Pollen and Mites. As in the analysis of PEI, the frequency of serious ADRs was based on the estimated number of administered
injections. Results:A total of 46 cases with serious ADRs were received. In 26 % of the cases, a serious ADR occurred during initial treatment aer the rst in-jection. In 82.6 % of the cases, the serious ADR occurred within the 30-minute observation period in the practice. Adrenaline was administered as
emergency treatment in seven cases. Hospitalisa-tions were initiated by the treating physician or by patients themselves in 45 cases. e duration of
the hospital stay varied from a few hours up to three days for further monitoring. Serious ADRs occurred in 11 cases with mites and in 35 cases
with pollen. If it is assumed that there are six in-jections in each vial, this yields an incidence of 0.00061 % (1 : 164,000). e frequency with mites (0.00093 %) was slightly higher than with pollen (0.00055 %).

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri: -
No. Panggil: Artikel
Penerbit: German : Springer., 2015
Deskripsi Fisik: -
Bahasa: English
ISBN/ISSN: DOI: 10.1007/s40629-
Klasifikasi: NONE
Tipe Isi: -
Tipe Media: -
Tipe Pembawa: -
Edisi: Allergo J Int 2015; 24: 294-302
Subjek: Medicine
Immunotherapy
Allergen
Drug
Info Detail Spesifik: -
Pernyataan Tanggungjawab: -

Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas

13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation

Komentar

Anda harus masuk sebelum memberikan komentar